Pfizer looks to right sterile injectable woes with modernized manufacturing

30th April 2020 Uncategorised 0

Pfizer has spent years on the receiving end of the FDA’s wrath for continued manufacturing issues surrounding the drugmaker’s 2015 buyout of Hospira. Now, after a year of trying to right the ship with that portfolio, Pfizer may have found its footing with supply on the upswing. 

More: Pfizer looks to right sterile injectable woes with modernized manufacturing
Source: fierce